PerkinElmer buys out British gene edit­ing play­er for $383M, boost­ing its di­ag­nos­tics and ge­nom­ic ca­pa­bilites

PerkinElmer, the Mass­a­chu­setts-based di­ag­nos­tics and life sci­ences com­pa­ny, has a new ac­qui­si­tion, and it comes with a near­ly $400 mil­lion price tag.

The com­pa­ny …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER